BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Louise Chen does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ACRSAclaris Therapeutics Inc | Buy | $9.00 | May 2025 | +288.9% | Miss |
| ACRSAclaris Therapeutics Inc | Buy | $15.00 | Mar 2025 | +97.9% | Miss |
 INVAInnoviva Inc | Buy | $55.00 | Mar 2025 | +21.4% | Miss |
 COGTCogent Biosciences Inc | Buy | $17.00 | Mar 2025 | +434.0% | Hit |
 GANXGain Therapeutics Inc | Buy | $12.00 | Mar 2025 | +51.2% | Miss |
 EWTXEdgewise Therapeutics Inc | Buy | $50.00 | Mar 2025 | −2.2% | Miss |
 SPRYARS Pharmaceuticals, Inc | Buy | $30.00 | Mar 2025 | −22.7% | Miss |
 ZLABZai Lab Ltd | Buy | $55.00 | Mar 2025 | −51.2% | Miss |
 CATXPerspective Therapeutics Inc. | Buy | $15.00 | Mar 2025 | +82.3% | Miss |
 ARDXArdelyx Inc | Buy | $15.00 | Mar 2025 | +11.4% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.